[Multipotent mesenchymal stromal cells application for acute graft versus host disease treatment].
Larisa A KuzminaNataliya A PetinatiV A VasilyevaMaria NareykoMikhail Yu DrokovYulia O DavydovaN M KapranovN V SatsYulia ChabaevaS M KulikovTatiana V GaponovaN I DrizeElena N ParovichnikovaS M KulikovPublished in: Terapevticheskii arkhiv (2020)
These data allow to select optimal samples for aGVHD treatment that can improve clinical results. aGVHD treatment with MSCs has shown efficacy comparable to other treatment approaches. Given the low percentage of complications and the absence of significant adverse effects, MSC therapy seems to be one of the optimal approaches to the treatment of resistant forms of GVHD.